| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MOLCEL.2003.08.016 |
| P5875 | ResearchGate publication ID | 9057934 |
| P50 | author | Stuart Schreiber | Q906562 |
| P2093 | author name string | Paul Nghiem | |
| Alykhan F Shamji | |||
| P2860 | cites work | Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin | Q28217173 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 271-280 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Integration of Growth Factor and Nutrient Signaling | |
| P478 | volume | 12 |
| Q38295728 | A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. |
| Q35551312 | A novel potent tumour promoter aberrantly overexpressed in most human cancers |
| Q24603024 | ARK5 is a tumor invasion-associated factor downstream of Akt signaling |
| Q37073356 | Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion |
| Q33357019 | An approach to analyse the specific impact of rapamycin on mRNA-ribosome association |
| Q38034270 | Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity |
| Q46500208 | Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis |
| Q35770177 | Development of novel targeted therapies in the treatment of malignant glioma |
| Q51658726 | Dietary Supplementation with α-Ketoglutarate Activates mTOR Signaling and Enhances Energy Status in Skeletal Muscle of Lipopolysaccharide-Challenged Piglets |
| Q38889267 | Differential Role of Rapamycin and Torin/KU63794 in Inflammatory Response of 264.7 RAW Macrophages Stimulated by CA-MRSA. |
| Q39427379 | Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells |
| Q24550891 | Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells |
| Q36103054 | EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy |
| Q42485894 | Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation |
| Q33836807 | Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). |
| Q40396199 | Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells |
| Q33927370 | Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo |
| Q39289182 | HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis |
| Q46353351 | IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma |
| Q24679076 | Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control |
| Q24304491 | Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway |
| Q45005936 | In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids |
| Q24338175 | Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway |
| Q34608059 | Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans |
| Q39026772 | LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies |
| Q46881358 | Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism |
| Q40147018 | MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells |
| Q28728958 | Mechanisms Limiting Body Growth in Mammals |
| Q41660894 | Melatonin and Hippo Pathway: Is There Existing Cross-Talk? |
| Q34688831 | Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer |
| Q24294199 | MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis |
| Q27938943 | Nutrient regulates Tor1 nuclear localization and association with rDNA promoter. |
| Q24297416 | PDK1, the master regulator of AGC kinase signal transduction |
| Q53331675 | PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling |
| Q37795727 | Protein Synthesis and the Antagonistic Pleiotropy Hypothesis of Aging |
| Q33697806 | Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response |
| Q36028214 | RNA polymerases I and III, growth control and cancer |
| Q34325486 | Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer |
| Q33389185 | Retracted: Central Exercise Action Increases the AMPK and mTOR Response to Leptin |
| Q52578518 | Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice |
| Q35893800 | Role of Prolactin Receptors in Lymphangioleiomyomatosis |
| Q34677806 | Role of TOR signaling in aging and related biological processes in Drosophila melanogaster |
| Q24320106 | SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling |
| Q24522447 | Signaling by target of rapamycin proteins in cell growth control |
| Q28291345 | Small molecules: the missing link in the central dogma |
| Q45182729 | Strain-induced vascular endothelial cell proliferation requires PI3K-dependent mTOR-4E-BP1 signal pathway |
| Q33841600 | The NF1 tumor suppressor critically regulates TSC2 and mTOR. |
| Q27933374 | The Ras/cAMP-dependent protein kinase signaling pathway regulates an early step of the autophagy process in Saccharomyces cerevisiae |
| Q35674453 | The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells |
| Q43179973 | The death effector domain-containing DEDD supports S6K1 activity via preventing Cdk1-dependent inhibitory phosphorylation. |
| Q38043507 | The promise of mTOR inhibitors in the treatment of colorectal cancer |
| Q34559580 | The translational response of the human mdm2 gene in HEK293T cells exposed to rapamycin: a role for the 5′-UTRs |
| Q45028059 | Tor signaling and nutrient-based signals converge on Mks1p phosphorylation to regulate expression of Rtg1.Rtg3p-dependent target genes |
| Q44915601 | Translational control of cell growth and malignancy by the CPEBs |
| Q28565319 | Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport |
| Q38004213 | mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy |
| Q53559277 | mTOR as a potential therapeutic target for treatment of keloids and excessive scars |
| Q39250062 | p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I γ Degradation and Cell Invasion. |
Search more.